Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)
Condition(s):Sickle Cell Disease; Hyperbaric Oxygen Therapy; Vaso-occlusive CrisisLast Updated:November 2, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Sickle Cell Disease; Hyperbaric Oxygen Therapy; Vaso-occlusive CrisisLast Updated:November 2, 2022Recruiting
Condition(s):Pulmonary FibrosisLast Updated:October 2, 2023Completed
Condition(s):Skin Ulcer Venous Stasis Chronic; Mixed Arteriovenous Leg UlcerLast Updated:March 18, 2020Withdrawn
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:February 1, 2022Unknown status
Condition(s):Cardiac Arrest; Shock; Lactic Acidosis; Thiamin DeficiencyLast Updated:August 9, 2022Terminated
Condition(s):COVID-19; Post COVID-19 Condition; Post COVID-19 Condition, Unspecified; Post COVID Condition; Post-COVID Syndrome; Post-Acute COVID-19 SyndromeLast Updated:March 19, 2024Active, not recruiting
Condition(s):Pulmonary Vascular Disorder; Pulmonary Artery Hypertension; Chronic Thromboembolic Pulmonary HypertensionLast Updated:October 16, 2023Active, not recruiting
Condition(s):HealthyLast Updated:March 21, 2023Not yet recruiting
Condition(s):HealthyLast Updated:May 14, 2012Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:August 6, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.